Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity-Reference-Cited by-同舟云学术

Serum anti-PAD4 autoantibodies are present in cystic fibrosis children and increase with age and lung disease severity

Published:2022-01-04 Issue:2 Volume:55 Page:109-117
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Linnemann Rachel W.¹,Yadav Ruchi²,Zhang Chao³,Sarr Demba²,Rada Balázs²,Stecenko Arlene A.¹

Affiliation:

1. Division of Pulmonology, Allergy/Immunology, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

2. Department of Infectious Diseases, College of Veterinary Medicine, The University of Georgia, Athens, GA, USA

3. Biostatistics Core, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA

Funder

Cystic Fibrosis Foundation

National Institutes of Health

National Centre for Advancing Translational Sciences

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08916934.2021.2021193

Reference24 articles.

1. Cystic fibrosis

2. A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis

3. Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening

4. Risk Factors for Bronchiectasis in Children with Cystic Fibrosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidyl arginine deiminase-4 inhibitor ameliorates pulmonary fibrosis through positive regulation of developmental endothelial locus-1;International Immunopharmacology;2024-10

2. The Cystic Fibrosis Transmembrane Regulator Controls Tolerogenic Responses to Food Allergens in Mice and Humans;2024-06-18

3. Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease;Cells;2023-12-13

4. Autoimmunity in people with cystic fibrosis;Journal of Cystic Fibrosis;2023-11

5. Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis;Rheumatology;2023-10-12